One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Access
PDF Availablehttps://doi.org/10.1136/jitc-2020-002255
Copy DOI
Export
Save
Share
Cite Journal: Journal for ImmunoTherapy of Cancer |  Publication Date: Jun 1, 2021 |
 Citations: 76 |  License type: open-access |
Affiliation: Monash University, Cabrini Hospital, University of Sydney, National Health and Medical Research Council, Calvary Mater Newcastle Hospital, Monash Medical Centre, Chris O’Brien Lifehouse, Prince of Wales Hospital, Mater Health Services, Mater Research, University of Queensland, Sir Charles Gairdner Hospital, QIMR Berghofer Medical Research Institute, Royal North Shore Hospital, Cancer Council Queensland, Peter MacCallum Cancer Centre
BackgroundIn this study, we assessed the activity of durvalumab, an antibody to programmed death ligand-1, in two cohorts of women with advanced endometrial cancers (AEC)—mismatch repair proficient (pMMR) and mismatch...
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
